UYKU APNE SENDROMU VE ENDOKRİNOLOJİ

Obstrüktif uyku apne sendromu (OUAS), uyku esnasında solunum durması sonucu oluşanyaygın görülen bir hastalıktır. Uykuda oluşan solunum bozuklukları neticesinde vücutta çeşitlimetabolik değişiklikler de meydana gelmektedir. Ayrıca bazı metabolik bozukluklar da uykudasolunum bozukluğu oluşumunu kolaylaştırmaktadır. Bu sebeple OUAS ile endokrinolojik, kardiyovasküler ve pulmoner bazı hastalıklar zaman zaman birliktelik göstermektedir.

Sleep Apne Syndrome and Endocrinology

Obstructive sleep apnea syndrome (OSAS) is a common disease that occurs as a result of respiratory pause during sleep. As a result of sleep related breathing disorders, various metabolic changes occur in the body. In addition; some metabolic disorders also facilitate sleep disordered breathing. For this reason, endocrinological, cardiovascular and pulmonary diseases occasionally coexist with OSAS.

PDF

___

1. Luboshitzky R, Aviv A, Hefetz A, Herer P, Shen-Orr Z, Lavie L, et al. Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. The Journal of clinical endocrinology and metabolism. 2002 Jul;87(7):3394-8.
2. Penev PD. Association between sleep and morning testosterone levels in older men. Sleep. 2007 Apr;30(4):427-32.
3. Gambineri A, Pelusi C, Pasquali R. Testosterone levels in obese male patients with obstructive sleep apnea syndrome: relation to oxygen desaturation, body weight, fat distribution and the metabolic parameters. Journal of endocrinological investigation. 2003 Jun;26(6):493-8.
4. Meston N, Davies RJ, Mullins R, Jenkinson C, Wass JA, Stradling JR. Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea. Journal of internal medicine. 2003 Nov;254(5):447-54.
5. Netzer NC, Eliasson AH, Strohl KP. Women with sleep apnea have lower levels of sex hormones. Sleep & breathing = Schlaf & Atmung. 2003 Mar;7(1):25-9.
6. Lanfranco F, Gianotti L, Pivetti S, Navone F, Rossetto R, Tassone F, et al. Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function. Clinical endocrinology. 2004 Jan;60(1):41-8.
7. Frey WC, Pilcher J. Obstructive sleep-related breathing disorders in patients evaluated for bariatric surgery. Obesity surgery. 2003 Oct;13(5):676-83.
8. O’Keeffe T, Patterson EJ. Evidence supporting routine polysomnography before bariatric surgery. Obesity surgery. 2004 Jan;14(1):23-6.
9. Schwartz AR, Patil SP, Laffan AM, Polotsky V, Schneider H, Smith PL. Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proceedings of the American Thoracic Society. 2008 Feb 15;5(2):185-92.
10. Dacal Quintas R, Tumbeiro Novoa M, Alves Perez MT, Santalla Martinez ML, Acuna Fernandez A, Marcos Velazquez P. Obstructive sleep apnea in normal weight patients: characteristics and comparison with overweight and obese patients. Archivos de bronconeumologia. 2013 Dec;49(12):513-7.
11. Piper AJ, Grunstein RR. Obesity hypoventilation syndrome: mechanisms and management. American journal of respiratory and critical care medicine. 2011 Feb 1;183(3):292-8.
12. Lin CC, Tsan KW, Chen PJ. The relationship between sleep apnea syndrome and hypothyroidism. Chest. 1992 Dec;102(6):1663-7.
13. Vgontzas AN. Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance? Archives of physiology and biochemistry. 2008 Oct;114(4):211-23.
14. Imayama I, Prasad B. Role of Leptin in Obstructive Sleep Apnea. Annals of the American Thoracic Society. 2017 Nov;14(11):1607-21.
15. Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes: a population-based study. American journal of respiratory and critical care medicine. 2005 Dec 15;172(12):1590-5.
16. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. American journal of epidemiology. 2004 Sep 15;160(6):521-30.
17. Chin K, Shimizu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation. 1999 Aug 17;100(7):706-12.
18. West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax. 2007 Nov;62(11):969-74.
19. Tasali E, Mokhlesi B, Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest. 2008 Feb;133(2):496- 506.
20. Tasali E, Leproult R, Ehrmann DA, Van Cauter E. Slow-wave sleep and the risk of type 2 diabetes in humans. Proceedings of the National Academy of Sciences of the United States of America. 2008 Jan 22;105(3):1044-9.
21. Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Annals of internal medicine. 2004 Dec 7;141(11):846-50.
22. Tiemeier H, Pelzer E, Jonck L, Moller HJ, Rao ML. Plasma catecholamines and selective slow wave sleep deprivation. Neuropsychobiology. 2002;45(2):81-6.
23. Davi MV, Dalle Carbonare L, Giustina A, Ferrari M, Frigo A, Lo Cascio V, et al. Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. European journal of endocrinology. 2008 Nov;159(5):533-40.
24. Weiss V, Sonka K, Pretl M, Dostalova S, Klozar J, Rambousek P, et al. Prevalence of the sleep apnea syndrome in acromegaly population. Journal of endocrinological investigation. 2000 Sep;23(8):515-9.
25. van Haute FR, Taboada GF, Correa LL, Lima GA, Fontes R, Riello AP, et al. Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging. European journal of endocrinology. 2008 Apr;158(4):459-65.
26. Bottini P, Tantucci C. Sleep apnea syndrome in endocrine diseases. Respiration; international review of thoracic diseases. 2003 May-Jun;70(3):320-7.
27. Grunstein RR, Sullivan CE. Sleep apnea and hypothyroidism: mechanisms and management. The American journal of medicine. 1988 Dec;85(6):775-9.
28. Rajagopal KR, Abbrecht PH, Derderian SS, Pickett C, Hofeldt F, Tellis CJ, et al. Obstructive sleep apnea in hypothyroidism. Annals of internal medicine. 1984 Oct;101(4):491-4.
29. Karakaş MS, Altekin RE, Baktır AO, Er A, Özbek SC, Yanıkoğlu A, et al. Obstrüktif Uyku Sendromu Olan Hastalarda Hipotiroidi Taraması Yapılmalı mı? Turgut Özal Tıp Merkezi Dergisi. 2011;18(4).
30. Güven F, Çiftçi B, Aydoğdu M. Obstrüktif uyku apne sendromu şüphesi olan olgularda hipotiroidi taraması yapılmalı mı. Türk Toraks Derneği VIII Yıllık Kongre. 2009;27.
31. Devdhar M, Ousman YH, Burman KD. Hypothyroidism. Endocrinology and metabolism clinics of North America. 2007 Sep;36(3):595-615.
32. Deegan PC, McNamara VM, Morgan WE. Goitre: a cause of obstructive sleep apnoea in euthyroid patients. The European respiratory journal. 1997 Feb;10(2):500-2.
33. Jha A, Sharma SK, Tandon N, Lakshmy R, Kadhiravan T, Handa KK, et al. Thyroxine replacement therapy reverses sleep-disordered breathing in patients with primary hypothyroidism. Sleep medicine. 2006 Jan;7(1):55-61.
34. Skjodt NM, Atkar R, Easton PA. Screening for hypothyroidism in sleep apnea. American journal of respiratory and critical care medicine. 1999 Aug;160(2):732-5.
35. Grunstein R. Obstructive sleep apnea syndrome and hypothyroidism. Chest. 1994 Apr;105(4):1296-7.
36. Barrett-Connor E, Dam TT, Stone K, Harrison SL, Redline S, Orwoll E. The association of testosterone levels with overall sleep quality, sleep architecture, and sleep-disordered breathing. The Journal of clinical endocrinology and metabolism. 2008 Jul;93(7):2602-9.
37. Grunstein RR, Handelsman DJ, Lawrence SJ, Blackwell C, Caterson ID, Sullivan CE. Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy. The Journal of clinical endocrinology and metabolism. 1989 Feb;68(2):352-8.
38. Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL, et al. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. The journals of gerontology Series A, Biological sciences and medical sciences. 2005 Nov;60(11):1451-7.
39. Liu PY, Swerdloff RS, Veldhuis JD. Clinical review 171: The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations. The Journal of clinical endocrinology and metabolism. 2004 Oct;89(10):4789-96.
40. Van Cauter E, Caufriez A, Kerkhofs M, Van Onderbergen A, Thorner MO, Copinschi G. Sleep, awakenings, and insulin-like growth factor-I modulate the growth hormone (GH) secretory response to GH-releasing hormone. The Journal of clinical endocrinology and metabolism. 1992 Jun;74(6):1451-9.
41. Van Cauter E, Kerkhofs M, Caufriez A, Van Onderbergen A, Thorner MO, Copinschi G. A quantitative estimation of growth hormone secretion in normal man: reproducibility and relation to sleep and time of day. The Journal of clinical endocrinology and metabolism. 1992 Jun;74(6):1441-50.
42. Issa FG, Sullivan CE. The immediate effects of nasal continuous positive airway pressure treatment on sleep pattern in patients with obstructive sleep apnea syndrome. Electroencephalography and clinical neurophysiology. 1986 Jan;63(1):10-7.
43. Attal P, Chanson P. Endocrine aspects of obstructive sleep apnea. The Journal of clinical endocrinology and metabolism. 2010 Feb;95(2):483-95.